KORU Medical Systems Presents Research on FreedomEDGE Syringe Infusion System at ONS Congress
KORU Medical Systems presented real-world data on the benefits of its FreedomEDGE Syringe Infusion System at the 51st Annual Oncology Nursing Society Congress, highlighting a study focused on reducing ergonomic strain during subcutaneous monoclonal antibody administration.
MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company presented its latest research at the Oncology Nursing Society (ONS) Congress, May 13-17. The poster at ONS was titled, “Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration.” The ONS abstract evaluated nur